• Science and Research

  CF Therapy Paves Way for Treating Children Ages 6 to 11 in Europe

  Posted by cystic-fibrosis-news-moderator on February 22, 2019 at 7:05 pm

  Symkevi improved the lung clearance in 6- to 11-year-old children with CF in a Phase 3 trial, which paves the way for its request for approval in Europe. Read more about this here.

  What are your thoughts on this news?

  cystic-fibrosis-news-moderator replied 5 years, 1 month ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply